Vet Eye Care Ltd 14881512 false 2023-05-19 2024-05-31 2024-05-31 The principal activity of the company is veterinary opthalmology services. Digita Accounts Production Advanced 6.30.9574.0 true 14881512 2023-05-19 2024-05-31 14881512 2024-05-31 14881512 core:RetainedEarningsAccumulatedLosses 2024-05-31 14881512 core:ShareCapital 2024-05-31 14881512 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 14881512 bus:SmallEntities 2023-05-19 2024-05-31 14881512 bus:AuditExemptWithAccountantsReport 2023-05-19 2024-05-31 14881512 bus:FullAccounts 2023-05-19 2024-05-31 14881512 bus:SmallCompaniesRegimeForAccounts 2023-05-19 2024-05-31 14881512 bus:RegisteredOffice 2023-05-19 2024-05-31 14881512 bus:Director1 2023-05-19 2024-05-31 14881512 bus:Director2 2023-05-19 2024-05-31 14881512 bus:Director3 2023-05-19 2024-05-31 14881512 bus:PrivateLimitedCompanyLtd 2023-05-19 2024-05-31 14881512 core:Buildings 2023-05-19 2024-05-31 14881512 core:FurnitureFittings 2023-05-19 2024-05-31 14881512 core:OfficeEquipment 2023-05-19 2024-05-31 14881512 core:PlantMachinery 2023-05-19 2024-05-31 14881512 countries:AllCountries 2023-05-19 2024-05-31 iso4217:GBP xbrli:pure

Registration number: 14881512

Vet Eye Care Ltd

Annual Report and Unaudited Filleted Abridged Financial Statements

for the Period from 19 May 2023 to 31 May 2024

 

Vet Eye Care Ltd

Contents

Abridged Balance Sheet

1

Notes to the Unaudited Abridged Financial Statements

2 to 3

 

Vet Eye Care Ltd

(Registration number: 14881512)
Abridged Balance Sheet as at 31 May 2024

Note

2024
£

Fixed assets

 

Tangible assets

4

690,920

Current assets

 

Stocks

5

13,274

Debtors

25,042

Cash at bank and in hand

 

309,369

 

347,685

Creditors: Amounts falling due within one year

(1,011,097)

Net current liabilities

 

(663,412)

Total assets less current liabilities

 

27,508

Provisions for liabilities

(18,368)

Net assets

 

9,140

Capital and reserves

 

Called up share capital

120

Profit and loss account

9,020

Total equity

 

9,140

For the financial period ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 11 February 2025 and signed on its behalf by:
 

Mr N Pallas

Director

Dr I Tzouganakis

Director

Mr M J Tarazi

Director

 

Vet Eye Care Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 19 May 2023 to 31 May 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU
Somerset

These financial statements were authorised for issue by the Board on 11 February 2025.

2

Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold Property

2% Straight line

Office Equipment

25% Straight line

Plant and Machinery

25% Straight line

Fixtures and Fittings

25% Straight line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

 

Vet Eye Care Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 19 May 2023 to 31 May 2024

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 4.

4

Tangible assets

Total
£

Cost or valuation

Additions

770,155

Disposals

(1,216)

At 31 May 2024

768,939

Depreciation

Charge for the period

78,019

At 31 May 2024

78,019

Carrying amount

At 31 May 2024

690,920

5

Stocks

2024
£

Stock

13,274